Bayer Aktiengesellschaft's (BAYZF) CEO Werner Baumann On Q3 2020 Results - Quick Version Earnings Call TranscriptSeeking Alpha • 11/03/20
Bayer Signs Letter of Intent to Build New Distribution Center in Saxonburg, PABusiness Wire • 10/27/20
Bayer Acquires Asklepios BioPharmaceutical to Broaden Innovation Base in Cell and Gene TherapyBusiness Wire • 10/26/20
Bayer's FIDELIO-DKD Phase III Study Demonstrated Investigational Drug Finerenone Significantly Reduced Renal and Cardiovascular Outcomes in Patients with Chronic Kidney Disease and Type 2 DiabetesBusiness Wire • 10/23/20
Bayer Submits Supplemental New Drug Application to FDA for Intrauterine Device (IUD) Mirena® (levonorgestrel-releasing intrauterine system) 52 mgBusiness Wire • 10/14/20
Bayer to Present Results From Phase III FIDELIO-DKD Study with Finerenone in Patients with Chronic Kidney Disease and Type 2 Diabetes during Late-Breaker Session at the American Society of Nephrology’s Kidney Week 2020Business Wire • 10/12/20